Operating Segments (Tables)

6 Months Ended

Mar. 31, 2013

Segment Revenue, Operating Income from Continuing Operations and Depreciation and Amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, as follows (in thousands):

	Three months ended						Six months ended
	March 31,						March 31,
	2013			2012			2013			2012
Revenue:
Medical Device	$	9,735		$	8,753		$	20,266		$	17,620
In Vitro Diagnostics		3,960			3,457			7,280			6,506
Total revenue	$	13,695		$	12,210		$	27,546		$	24,126
Operating income (loss):
Medical Device	$	4,785		$	4,121		$	10,625		$	8,053
In Vitro Diagnostics		1,267			1,271			2,018			2,177
Total segment operating income		6,052			5,392			12,643			10,230
Corporate		(1,923	)		(1,703	)		(3,637	)		(3,319	)
Total operating income from continuing operations	$	4,129		$	3,689		$	9,006		$	6,911
Depreciation and amortization:
Medical Device	$	311		$	354		$	628		$	718
In Vitro Diagnostics		218			194			433			389
Corporate		195			183			385			373
Total depreciation and amortization	$	724		$	731		$	1,446		$	1,480